Alpha 2.0
Login Register
» Articles » PMID: 15117918

Profibrotic Effects of Angiotensin II in the Heart: a Matter of Mediators

Overview
Journal Hypertension
Date 2004 May 1
PMID 15117918
Citations 6
Authors
Javier Diez
Affiliations
Soon will be listed here.
Citing Articles

Supplementation with the Postbiotic BPL1™-HT (Heat-Inactivated subsp. Lactis) Attenuates the Cardiovascular Alterations Induced by Angiotensin II Infusion in Mice.

de la Fuente-Munoz M, Roman-Carmena M, Amor S, Gonzalez-Hedstrom D, Martinez-Rios V, Martorell P Antioxidants (Basel). 2025; 14(2).

PMID: 40002381 PMC: 11851978. DOI: 10.3390/antiox14020193.

Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics.

Sarohi V, Chakraborty S, Basak T Front Mol Biosci. 2022; 9:1030226.

PMID: 36483540 PMC: 9722982. DOI: 10.3389/fmolb.2022.1030226.

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction.

Graziani F, Lillo R, Crea F Front Cardiovasc Med. 2021; 8:678530.

PMID: 33969025 PMC: 8100203. DOI: 10.3389/fcvm.2021.678530.

Increased Renal Dysfunction, Apoptosis, and Fibrogenesis Through Sympathetic Hyperactivity After Focal Cerebral Infarction.

Cai Y, Lu X, Cheng X, Lv Q, Xu G, Liu X Transl Stroke Res. 2021; 13(4):641-651.

PMID: 33713029 DOI: 10.1007/s12975-021-00900-w.

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?.

Sweeney M, Corden B, Cook S EMBO Mol Med. 2020; 12(10):e10865.

PMID: 32955172 PMC: 7539225. DOI: 10.15252/emmm.201910865.